Clinical Sites

Accelovance research-dedicated clinical sites are optimized for productivity; combining proven patient recruitment efforts with properly resourced staff and engaged PIs. Predictable, controlled enrollment of quality patients is the value Accelovance offers through enhanced greater control over site operations, quality, resource allocation, and recruitment activities.

We provide honest study assessments and feasibilities and are careful to take on studies ONLY when we are confident that our sites are the best match. From high volume enrollment (Phase II ~600 patients, 5 sites, 4 days) to controlled safety cohort management for Phase I studies, they are ideally situated to support Phase I-IV primary care and general health therapeutic areas as well as healthy volunteer and vaccine studies.

How can Accelovance sites benefit your next program?


Huntsville, AL Melbourne, FL Peoria, IL
Rockville/DC San Diego, CA South Bend, IN



Site Features
  • Accelovance database of 60,000 pre-screened Subjects
  • Phase I-IV (outpatient) clinical studies optimized for controlled enrollment
  • Accelovance owned / operated / staffed
  • Engaged PIs supported by full-time Accelovance staff
  • Designated monitoring space
  • Sponsor dedicated enrollment days
Flexibility
  • Working through central IRBs
  • A single contract and budget for all sites
  • Serving Other CROs or Sponsors directly
  • Utilize a single site or multiple sites  
  • Select sites based on location and/or population needs 
Standardized Quality
  • Client Priority
  • Centralized SOPs operate across all sites for highest standard of quality
  • Corporate training programs (internal and external)
  • ICH GCP certified